Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 0

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 0
---
<div align='center'>UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934</div>

Filed by the Registrant x

Filed by a Party other than the Registrant ¨

Check the appropriate box:

¨ Preliminary
Proxy Statement

¨
Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

x Definitive Proxy
Statement

¨
Definitive Additional Materials

¨
Soliciting Material under §240.14a-12

<div align='center'>PETROS PHARMACEUTICALS, INC.

(Name of Registrant as Specified in its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)</div>

Payment of Filing Fee (Check all boxes that apply):

x No fee required

¨
Fee paid previously with preliminary materials

¨
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

March 18, 2025

To Our Stockholders:

On behalf of the Board of
Directors (the “Board”) of Petros Pharmaceuticals, Inc. (the “Company,” “Petros,” “our”
or “we”), I cordially invite you to attend our 2025 special meeting of stockholders (the “Special Meeting”)
at 10 a.m. Eastern Time on Thursday, April 10, 2025. To provide access to our stockholders regardless of geographic location,
this year’s Special Meeting will be held in a virtual-only meeting format at www.virtualshareholdermeeting.com/PTPI2025SM.

Details regarding the meeting,
the business to be conducted at the Special Meeting and information about Petros that you should consider when you vote your shares are
described in the accompanying Notice of Special Meeting of Stockholders (“Notice”), the Proxy Statement and the proxy card.
We urge you to review these materials carefully and to vote your shares electronically via the Internet or by completing and returning
the proxy card or voting instruction form. Our Proxy Statement is available at www.proxyvote.com.

At the Special Meeting, we
will ask stockholders to: (i) approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares